<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04373850</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00097613</org_study_id>
    <nct_id>NCT04373850</nct_id>
  </id_info>
  <brief_title>Reducing Readmission Rates by Providing a Comprehensive Transition Plan From Hospital to Home for Cardiac Surgery Patients.</brief_title>
  <official_title>Reducing Readmission Rates by Providing a Comprehensive Transition Plan From Hospital to Home for Cardiac Surgery Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients who undergo cardiac surgery will be screened by a team member with the risk score
      once the patient has been admitted to the Cardiovascular Progressive Care Unit (CVPCU) after
      surgery. Participants will be randomized to the intervention or the control group. Both
      groups will receive standard discharge planning. In addition, the intervention group will
      have a nurse practitioner (NP) who will be responsible to verify that each essential step of
      the discharge process has been completed and will visit the patient in patient's home after
      discharge to complete a physical, review medications, titrate medications as needed,
      prescribe any necessary treatments, and perform education. The primary outcome variable will
      be a decrease in the 30 day readmission rate comparing high risk patients at pre and post
      intervention.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 23, 2016</start_date>
  <completion_date type="Actual">March 26, 2020</completion_date>
  <primary_completion_date type="Actual">March 26, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>30-Day readmission rate</measure>
    <time_frame>Up to 30 days post discharge</time_frame>
    <description>Rate of readmissions within 30 days after discharge</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">450</enrollment>
  <condition>Cardiac Surgery</condition>
  <arm_group>
    <arm_group_label>Home visit group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Will receive a home visit after discharge in addition to the standard discharge planning.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Will receive only the standard discharge planning.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Home Visit</intervention_name>
    <description>Physical exam, medication dose titration</description>
    <arm_group_label>Home visit group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients 18 years of age or greater who have had cardiac surgery procedures
             including coronary artery bypass surgery (CABG), valve replacement, aortic aneurysm
             repair, and combined CABG and valve procedures.

        Exclusion Criteria:

          -  Patients who have undergone orthotopic heart transplantation, orthotopic lung
             transplantation, or orthotopic heart-lung transplantation

          -  Patients who have undergone ventricular assist device placement

          -  Patients who do not reside in Maryland

          -  Non English speaking patients

          -  Patients discharged to a facility.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sharon Owens, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 30, 2020</study_first_submitted>
  <study_first_submitted_qc>April 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 5, 2020</study_first_posted>
  <last_update_submitted>April 30, 2020</last_update_submitted>
  <last_update_submitted_qc>April 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Reducing readmissions</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

